Tabular foundation model predicts alternative lengthening of telomeres (ALT) and identifies SMARCAL1 as a target in ALT-driven cancers
Bennett, D.; Wierdl, M.; Chakraborty, S.; Johnson, J. D.; Akingbehin, V.; Estevez-Prado, D.; Feng, Y.; Morsby, J. J.; Harper, J.; Mohammad, M. N. A.; Pan, M.; Ocasio-Martinez, N.; Catlett, J. L.; Nations, T. B.; Dharia, N. V.; Robichaud, A.; Herman, A.; Zhang, S.; Kelly, J.; Steele, J.; Rusch, M.; Wienand, K.; Campbell, C. D.; Alexe, G.; Vazquez, F.; Getz, G.; Roberts, C. W.; Mullighan, C. G.; Sweet-Cordero, E. A.; Reynolds, C. P.; Koneru, B.; Shelat, A. A.; Durbin, A. D.; Bernstein, E.; Ma, X.; Stegmaier, K.; Geeleher, P.; Guenther, L. M.
Show abstract
Alternative lengthening of telomeres (ALT) is a telomerase-independent pathway used by aggressive cancers to maintain their replicative immortality. Because ALT is absent from normal human cells, it is an appealing target for cancer therapy, but the lack of ability to determine ALT status at scale has hindered target discovery. Here, we developed ALTitude, a tabular foundation model-based method that infers ALT from cell line whole-genome sequencing data, without need for paired germline sequences. We deployed ALTitude across the Cancer Dependency Map, doubling the number of known ALT+ cancer models. Systematic integration of ALTitude with CRISPR-Cas9 screens yielded the selective dependency on SMARCAL1 in ALT+ cell lines, where we show it stabilizes the ALT phenotype. Acute depletion of SMARCAL1 leads to G2/M arrest, mitotic catastrophe, and cell death. These data provide a valuable resource for studying ALT-related genomic features and present SMARCAL1 as a therapeutically relevant drug target for ALT+ malignancies.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Human aneuploid cells depend on the RAF/MEK/ERK pathway for overcoming increased DNA damage 98%
- YAP-Driven Oral Epithelial Stem Cell Malignant Reprogramming at Single Cell Resolution 98%
- ANP32E drives vulnerability to ATR inhibitors by inducing R-loops-dependent Transcription Replication Conflicts in Triple Negative Breast Cancer 98%
Similar papers in this journal
- Increased RNA and protein degradation is required for counteracting transcriptional burden and proteotoxic stress in human aneuploid cells 98%
- FH variant pathogenicity promotes purine salvage pathway dependence in kidney cancer 97%
- A molecular switch between mammalian MLL complexes dictates response to Menin-MLL inhibition 97%
Similar papers in this journal
- The neuroendocrine transition in prostate cancer is dynamic and dependent on ASCL1 97%
- Spatial proteomic characterization of HER2-positive breast tumors through neoadjuvant therapy predicts response 97%
- Multi-modal digital pathology for colorectal cancer diagnosis by high-plex immunofluorescence imaging and traditional histology of the same tissue section 97%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.